Sep 11, 2026 09:00AM
Jun 23, 2026 08:30AM
Jun 16, 2026 09:15AM
Jun 16, 2026 09:15AM
Jun 10, 2026 09:15AM
Jun 10, 2026 09:15AM
Jun 4, 2026 10:01AM Nexalin Technology receives U.S. patent for neurostimulation method
Jun 4, 2026 10:00AM
May 21, 2026 08:33AM
May 21, 2026 08:31AM
May 21, 2026 08:30AM
May 21, 2026 08:30AM
May 19, 2026 08:30AM
May 19, 2026 08:30AM Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
Apr 28, 2026 09:15AM
Apr 28, 2026 09:15AM
Apr 22, 2026 09:35AM
Apr 22, 2026 09:35AM
Apr 15, 2026 10:00AM
Apr 15, 2026 10:00AM
Apr 9, 2026 07:47AM Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
Feb 24, 2026 08:07AM
Feb 23, 2026 08:18AM
Feb 13, 2026 09:00AM
Feb 2, 2026 08:45AM
Feb 2, 2026 08:45AM
Dec 3, 2025 08:03AM
Dec 3, 2025 08:00AM Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program
Nov 5, 2025 08:31AM
Nov 5, 2025 08:30AM
Oct 17, 2025 09:00AM
Apr 2, 2025 08:34AM
Apr 2, 2025 08:30AM
Feb 28, 2025 08:30AM
Oct 14, 2024 08:30AM Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs
Apr 10, 2024 08:35AM
Apr 10, 2024 08:30AM
Mar 27, 2023 07:00AM
Jan 24, 2023 08:30AM
Jan 5, 2023 08:30AM
Jan 4, 2022 06:10AM

331,502 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All